Problems and prospects of new immunotherapeutic approaches.

Abstract

Active immunotherapy of cancer is based on the hyperactivation of the immune system of tumor-bearing patients. Interleukin 2 (IL2) has proven to be the most potent immunostimulant used so far. Therapeutic activity of IL2 and IL2-activated lymphocytes has been reported in the treatment of certain tumors such as metastatic melanoma and renal carcinoma… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.